Decoding cancer – Defining the optimal treatment option for each individual patient

Early detection of potentially fatal diseases and the selection of suitable therapies are crucial for successful treatment. BioNTech Diagnostics is working to provide innovative products and services to help medical professionals diagnose and characterize diseases with the final goal of extending the lives of patients and improving their quality of life. The Company currently focuses on the development of new diagnostic products and services in oncology.

We recently introduced MammerTyper®, a molecular in vitro diagnostic test for the quantitative detection of the mRNA expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue. MammerTyper® has been shown in a variety of scientific publications to offer superior diagnostics insights compared to conventional immunohistochemical detection methods.

More Information about MammaTyper®

For more details about MammaTyper® and for distributor information please visit our website: www.mammatyper.com